Decreased half life of cyclophosphamide in patients under continual treatment

Eur J Cancer (1965). 1979 Jan;15(1):7-10. doi: 10.1016/0014-2964(79)90198-1.
No abstract available

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Cyclophosphamide / blood
  • Cyclophosphamide / metabolism*
  • Cyclophosphamide / therapeutic use
  • Female
  • Half-Life
  • Humans
  • Injections, Intravenous
  • Middle Aged
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism*

Substances

  • Cyclophosphamide